Clinical Trial Update: Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing rapid dose escalation of quetiapine versus conventional escalation in acute schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED